catechin has been researched along with Cardiovascular Stroke in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (25.93) | 29.6817 |
| 2010's | 13 (48.15) | 24.3611 |
| 2020's | 7 (25.93) | 2.80 |
| Authors | Studies |
|---|---|
| Ponnian, SMP | 1 |
| Aldahmash, W; Alwasel, S; Del Mar Contreras, M; Feriani, A; Gómez-Caravaca, AM; Harrath, AH; Hichem, A; Mnafgui, K; Segura-Carretero, A; Taamalli, A; Tir, M; Tlili, N | 1 |
| Chen, L; Gan, X; Jian, J; Liang, R; Wang, R; Yu, Q; Zhang, N | 1 |
| Guo, QH; Liu, JJ; Liu, Y; Wei, XY; Yin, N; Zeng, WJ; Zeng, YF | 1 |
| Li, P; Qin, T; Sun, D; Wang, J; Zhang, B; Zhao, X | 1 |
| Curtis, JR; Owensby, JK; Xie, F | 1 |
| He, H; He, S; Jiang, Q; Jiao, Y; Tu, Q; Xu, M; Zheng, W | 1 |
| Chen, ZZ; Dou, J; Lei, SQ; Leng, Y; Meng, QT; Wu, Y; Xia, ZY; Zhao, B; Zhu, J | 1 |
| Prince, PS | 2 |
| Calzada, C; Ceballos, G; Meaney, E; Ortiz, A; Ortiz-Vilchis, P; Ramirez-Sanchez, I; Romero-Perez, D; Rubio-Gayosso, I; Taub, P; Villarreal, F; Yamazaki, KG | 1 |
| Moreno-Ulloa, A; Moreno-Ulloa, J | 1 |
| Chang, H; Lin, CM; Shyu, KG; Wang, BW | 1 |
| Dardor, M; El-Missiry, MA; Elkomy, MM; Othman, AI | 1 |
| Devika, PT; Stanely Mainzen Prince, P | 3 |
| Barraza-Hidalgo, M; Ceballos, G; Cortez-Gomez, B; Cruz, M; Rivas, M; Romero-Perez, D; Villarreal, F; Yamazaki, KG | 1 |
| Chun, KJ; Jang, Y; Kim, JH; Lee, D; Song, DK; Xu, Z | 1 |
| Barraza-Hidalgo, M; Ceballos, G; Rivas, MM; Taub, PR; Villarreal, FJ; Yamazaki, KG; Zambon, AC | 1 |
| Bonds, JA; Dalton, ND; Head, BP; Horikawa, YT; Panneerselvam, M; Patel, HH; Patel, PM; Roth, DM; Saldana, M; Tsutsumi, YM | 1 |
| Chen, X; Gao, H; Guo, TZ; Hou, YL; Kobayashi, H; Sun, SC; Tang, JS; Yao, XS; Ye, WC | 1 |
| Stanely Mainzen Prince, P | 2 |
| Gitti, G; Knight, RA; Latchman, DS; Menegazzi, M; Pasini, E; Scarabelli, TM; Stephanou, A; Suzuki, H; Townsend, PA | 1 |
| Devika, PT; Mainzen Prince, PS | 1 |
| Devika, PT; Prince, PS | 1 |
1 review(s) available for catechin and Cardiovascular Stroke
| Article | Year |
|---|---|
Cardioprotective effect of epigallocatechin gallate in myocardial ischemia/reperfusion injury and myocardial infarction: a meta-analysis in preclinical animal studies.
Topics: Animals; Animals, Laboratory; Catechin; Myocardial Infarction; Myocardial Reperfusion Injury | 2023 |
26 other study(ies) available for catechin and Cardiovascular Stroke
| Article | Year |
|---|---|
Preventive effects of (-) epicatechin on tachycardia, cardiac hypertrophy, and nuclear factor- κB inflammatory signaling pathway in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Cardiomegaly; Catechin; Isoproterenol; Male; Myocardial Infarction; NF-kappa B; Rats; Rats, Wistar; Signal Transduction; Tachycardia | 2022 |
In vivo evaluation and molecular docking studies of Schinus molle L. fruit extract protective effect against isoproterenol-induced infarction in rats.
Topics: Anacardiaceae; Animals; Antioxidants; bcl-2-Associated X Protein; Biomarkers; Caspase 3; Catechin; Fibrinolytic Agents; Fruit; Isoproterenol; Lipids; Molecular Docking Simulation; Myocardial Infarction; Myocardium; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Tandem Mass Spectrometry; Transforming Growth Factor beta1 | 2022 |
EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p/ACSL4 axis.
Topics: Animals; Catechin; Disease Models, Animal; Mice; MicroRNAs; Myocardial Infarction; Myocardial Ischemia | 2023 |
Protective effect of epigallocatechin-3-gallate against neuroinflammation and anxiety-like behavior in a rat model of myocardial infarction.
Topics: Animals; Anxiety; Apoptosis; Catechin; Hippocampus; Myocardial Infarction; Rats | 2020 |
Comparative safety of flavocoxid vs prescription NSAIDs among osteoarthritis patients.
Topics: Acute Kidney Injury; Adult; Aged; Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents, Non-Steroidal; Catechin; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Osteoarthritis; Polypharmacy; Proportional Hazards Models | 2020 |
EGCG decreases myocardial infarction in both I/R and MIRI rats through reducing intracellular Ca2+ and increasing TnT levels in cardiomyocytes.
Topics: Animals; Apoptosis; Calcium; Catechin; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Troponin T | 2021 |
(-)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions.
Topics: Animals; Apoptosis; Cardiotonic Agents; Catechin; Diabetes Mellitus, Experimental; Hyperglycemia; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Sirtuin 1; Superoxide Dismutase | 2017 |
(-) Epicatechin prevents alterations in lysosomal glycohydrolases, cathepsins and reduces myocardial infarct size in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Catechin; Cathepsin B; Cathepsin D; Glycoside Hydrolases; Isoproterenol; Lysosomes; Male; Myocardial Infarction; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Troponin I | 2013 |
Co-administration of the flavanol (-)-epicatechin with doxycycline synergistically reduces infarct size in a model of ischemia reperfusion injury by inhibition of mitochondrial swelling.
Topics: Animals; Cardiotonic Agents; Catechin; Coronary Vessels; Doxycycline; Drug Synergism; Flavonoids; Male; Mitochondria, Heart; Mitochondrial Swelling; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2014 |
Mortality reduction among persons with type 2 diabetes: (-)-Epicatechin as add-on therapy to metformin?
Topics: Animals; Cardiovascular Diseases; Catechin; Chocolate; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Metformin; Myocardial Infarction; Rats; Reperfusion Injury | 2016 |
Suppressive effect of epigallocatechin-3-O-gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo.
Topics: Angiotensin II; Animals; Anthracenes; Catechin; Cell Proliferation; Cells, Cultured; Endoglin; Fibrosis; Heart Failure; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; Models, Biological; Myocardial Infarction; Myocardium; Promoter Regions, Genetic; Protein Binding; Rats, Wistar; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1 | 2016 |
Epigallocatechin-3-gallate prevents cardiac apoptosis by modulating the intrinsic apoptotic pathway in isoproterenol-induced myocardial infarction.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Body Weight; Catechin; Cytoprotection; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar | 2017 |
(-)Epigallocatechingallate protects the mitochondria against the deleterious effects of lipids, calcium and adenosine triphosphate in isoproterenol induced myocardial infarcted male Wistar rats.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Calcium; Catechin; Cholesterol; Fatty Acids, Nonesterified; Isoproterenol; Lipid Peroxides; Lipids; Male; Mitochondria, Heart; Myocardial Infarction; Phospholipids; Protective Agents; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Thiobarbituric Acid Reactive Substances; Triglycerides | 2008 |
Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury.
Topics: Administration, Oral; Animals; Cardiovascular Agents; Catechin; Disease Models, Animal; Drug Administration Schedule; Hemodynamics; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Peroxidase; Rats; Rats, Sprague-Dawley; Time Factors | 2008 |
Polyphenol (-)-epigallocatechin gallate during ischemia limits infarct size via mitochondrial K(ATP) channel activation in isolated rat hearts.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Catechin; Decanoic Acids; Glyburide; Heart; Hemodynamics; Humans; Hydroxy Acids; KATP Channels; Male; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Potassium Channel Blockers; Rats; Rats, Wistar | 2010 |
Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion.
Topics: Administration, Oral; Analysis of Variance; Animals; Catechin; Coronary Circulation; Coronary Occlusion; Disease Models, Animal; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Probability; Radiography; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Survival Rate; Treatment Outcome; Ventricular Remodeling | 2010 |
Dark chocolate receptors: epicatechin-induced cardiac protection is dependent on delta-opioid receptor stimulation.
Topics: Animals; Cacao; Catechin; Decanoic Acids; Dose-Response Relationship, Drug; Hydroxy Acids; Male; Mice; Mice, Inbred C57BL; Models, Animal; Myocardial Infarction; Myocardial Reperfusion Injury; Naloxone; Naltrexone; Potassium Channel Blockers; Receptors, Cell Surface; Receptors, Opioid, delta | 2010 |
Polyphenols from Parabarium huaitingii and their positive inotropic and anti-myocardial infarction effects in rats.
Topics: Animals; Apocynaceae; Calcium; Cardiotonic Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Heart; Medicine, Chinese Traditional; Myocardial Contraction; Myocardial Infarction; Plant Extracts; Plant Stems; Plants, Medicinal; Proanthocyanidins; Prohibitins; Random Allocation; Rats; Rats, Wistar; Stimulation, Chemical | 2011 |
A biochemical, electrocardiographic, electrophoretic, histopathological and in vitro study on the protective effects of (-)epicatechin in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Biomarkers; Biphenyl Compounds; Cardiotonic Agents; Catechin; Dose-Response Relationship, Drug; Electrocardiography; Electrophoresis; Free Radical Scavengers; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Picrates; Rats; Rats, Wistar | 2011 |
Preventive effects of (-) epicatechin on altered adenosine triphosphatases and minerals in isoproterenol-induced myocardial infarcted rats.
Topics: Adenosine Triphosphatases; Animals; Catechin; Isoproterenol; Lipid Peroxidation; Male; Minerals; Myocardial Infarction; Rats; Rats, Wistar | 2012 |
(-) Epicatechin attenuates mitochondrial damage by enhancing mitochondrial multi-marker enzymes, adenosine triphosphate and lowering calcium in isoproterenol induced myocardial infarcted rats.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Biomarkers; Calcium; Catechin; Citric Acid Cycle; Creatine Kinase; Disease Models, Animal; Electron Transport Complex IV; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hydroxyl Radical; Isocitrates; Isoproterenol; Ketoglutaric Acids; L-Lactate Dehydrogenase; Lipid Peroxidation; Malates; Male; Microscopy, Electron, Transmission; Mitochondria, Heart; Myocardial Infarction; NADH Dehydrogenase; Rats; Rats, Wistar; Succinic Acid; Superoxide Dismutase; Troponin I | 2013 |
Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis.
Topics: Administration, Oral; Animals; Animals, Newborn; Apoptosis; Caspases; Catechin; Cell Survival; Cells, Cultured; DNA-Binding Proteins; Enzyme Activation; Heart; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Phosphorylation; Plant Extracts; Rats; Reperfusion Injury; STAT1 Transcription Factor; Tea; Trans-Activators | 2004 |
Protective effect of (-)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: a histopathological study.
Topics: Animals; Catechin; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar | 2008 |
(-)-Epigallocatechin gallate (EGCG) prevents isoprenaline-induced cardiac marker enzymes and membrane-bound ATPases.
Topics: Adenosine Triphosphatases; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Calcium; Catechin; Creatine Kinase; Creatine Kinase, MB Form; Dose-Response Relationship, Drug; Enzyme Activation; Heart; Isoenzymes; Isoproterenol; L-Lactate Dehydrogenase; Male; Membrane Proteins; Molecular Structure; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Stereoisomerism | 2008 |
Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats.
Topics: Animals; Cardiovascular Agents; Catechin; Disease Models, Animal; Heart; Isoproterenol; Lysosomes; Male; Myocardial Infarction; Rats; Rats, Wistar; Subcellular Fractions; Time Factors | 2008 |
(-)Epigallocatechin-gallate (EGCG) prevents mitochondrial damage in isoproterenol-induced cardiac toxicity in albino Wistar rats: a transmission electron microscopic and in vitro study.
Topics: Animals; Antioxidants; Catalase; Catechin; Free Radical Scavengers; Glutathione; In Vitro Techniques; Isoproterenol; Lipid Peroxides; Male; Microscopy, Electron, Transmission; Mitochondria, Heart; Myocardial Infarction; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2008 |